NXP Semiconductors N.V. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NXP Semiconductors N.V. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	9,498	9,256	9,407	8,877	8,612	11,063	13,205	13,276	12,614	12,269
Cost of revenue	5,429	4,637	4,556	4,259	4,377	4,996	5,688	5,723	5,495	5,553
Gross profit	4,069	4,619	4,851	4,618	4,235	6,067	7,517	7,553	7,119	6,716
Research and development	1,560	1,554	1,700	1,643	1,725	1,936	2,148	2,418	2,347	2,360
Selling, general and administrative	1,141	1,090	993	924	879	956	1,066	1,159	1,164	1,204
Operating expenses		4,092	4,142	4,002	3,931	3,484	3,723	3,877	3,647	3,681
Operating income	-150	2,102	2,710	641	418	2,583	3,797	3,661	3,417	3,047
Interest expense	408	310	273	370	362	369	427	438	398	466
Other non-operating income	-453	-366	-335	-350	-417	-403	-434	-309	-318	-384
Pre-tax income	-603	1,736	2,375	291	1	2,180	3,363	3,352	3,099	2,663
Income tax	-851	-483	176	20	-83	272	529	523	545	525
Net income to minority interests	59	57	50	29	28	35	46	25	32	47
Net income	200	2,215	2,208	243	52	1,871	2,787	2,797	2,510	2,021
EBITDA	2,055	4,275	4,697	2,688	2,406	3,845	5,047	4,767	4,342	3,879
EPS, basic	0.59	6.54	6.78	0.86	0.19	6.91	10.64	10.83	9.84	8.00
EPS, diluted	0.58	6.41	6.72	0.85	0.18	6.79	10.55	10.70	9.73	7.95
Shares, basic (weighted)	338	339	326	282	280	271	262	258	255	253
Shares, diluted (weighted)	348	346	329	286	284	276	264	261	258	254
Dividend per share		0.00	0.50	1.25	1.50	2.25	3.38	4.06	4.06	4.06

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	1,894	3,547	2,789	1,045	2,275	2,830	3,845	3,862	3,292	3,267
Receivables	1,033	879	792	667	765	923	960	894	1,032	1,055
Inventory	1,113	1,236	1,279	1,192	1,030	1,189	1,782	2,134	2,356	2,577
Other current assets	254	382	365	313	254	286	348	565	625	669
Total current assets	5,398	6,044	5,225	3,267	4,324	5,228	6,935	7,864	7,305	7,940
Property, plant and equipment	2,352	2,295	2,436	2,448	2,284	2,635	3,105	3,323	3,267	2,977
Lease right-of-use assets				226	223	226	250	250	265	256
Goodwill	8,843	8,866	8,857	9,949	9,984	9,961	9,943	9,955	9,930	10,299
Intangible assets	9,512	9,335	9,183	3,620	2,242	1,694	1,311	922	836	1,547
Other non-current assets	962	981	545	732	1,013	1,346	1,942	1,297	1,796	2,584
Total assets	24,898	24,049	21,530	20,016	19,847	20,864	23,236	24,353	24,385	26,560
Accounts payable	973	1,146	999	944	991	1,252	1,185	1,164	1,017	997
Accrued liabilities	712	747	1,219
Short-term debt	421	751	1,107	0	0	0	0	1,000	500	1,250
Total current liabilities	2,433	2,718	3,385	1,791	2,017	2,452	3,270	4,111	3,098	3,881
Long-term debt	8,766	5,814	6,247	7,365	7,609	10,572	11,165	10,175	10,354	10,972
Lease liabilities				176	177	181	202	204	223	215
Other non-current liabilities	862	1,085	753	923	971	1,001	1,015	1,098	1,392	1,175
Total liabilities	13,742	10,333	10,840	10,361	10,696	14,094	15,496	15,393	14,854	16,109
Total debt	9,187	6,565	7,354	7,400	7,650	10,650	11,250	11,250	10,420	11,040
Paid-in capital	15,679	15,960	15,460	15,184	14,133	13,727	14,091	14,501	14,962	15,424
Retained earnings	-3,934	-2,339	-1,907	-2,845	-4,328	-5,371	-3,975	-2,793	-1,814	-1,354
Treasury stock	-915	-342	-3,238	-3,037	-1,037	-1,932	-2,799	-3,210	-4,004	-4,283
Other comprehensive income	34	177	123	75	117	48	76	90	-17	213
Shareholders' equity	10,935	13,527	10,505	9,441	8,944	6,528	7,449	8,644	9,183	10,056
Minority interests	221	189	185	214	207	242	291	316	348	395
Total equity	11,156	13,716	10,690	9,655	9,151	6,770	7,740	8,960	9,531	10,451
Total liabilities and equity	24,898	24,049	21,530	20,016	19,847	20,864	23,236	24,353	24,385	26,560

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	259	2,272	2,258	272	80	1,906	2,833	2,822	2,542	2,068
Depreciation and amortization	2,205	2,173	1,987	2,047	1,988	1,262	1,250	1,106	925	832
Stock-based compensation	338	281	314	346	384	353	364	411	461	462
Deferred income tax	-925	-797	-211	-175	-349	-20	-236	-267	-272	-8
Change in inventory	568	-120	-65	128	163	-159	-593	-353	-222	-308
Change in payables	-156	225	-129	-460	319	248	633	-119	-188	-50
Cash from operations	2,303	2,447	4,369	2,373	2,482	3,077	3,895	3,513	2,782	2,820
Capital expenditures	-389	-552	-611	-526	-392	-767	-1,063	-827	-727	-397
Acquisitions	-202	0	-18	-1,698	-34	-23	-27	0	0	-1,175
Purchases of investments		0	-9	-19	-30	-8	-20	-94	-260	-649
Sales and maturities of investments		0	2	1	2	8	13	0	5	2
Cash from investing	-627	2,072	-522	-2,284	-418	-934	-1,249	-1,508	-686	-2,357
Debt issued	3,259	0	1,997	1,750	2,000	4,000	1,496	0	670	1,868
Debt repaid	-38	-16	-1
Stock issued	115	233	39	84	72	62	59	71	82	83
Share buybacks	-1,280	-286	-5,006	-1,443	-627	-4,015	-1,426	-1,053	-1,373	-899
Dividends paid	0	0	-74	-319	-420	-562	-815	-1,006	-1,038	-1,025
Cash from financing	-1,392	-2,886	-4,597	-1,831	-835	-1,585	-1,619	-1,990	-2,662	-494
Exchange rate effect	-4	20	-8	-2	1	-3	-12	2	-4	6
Net change in cash	280	1,653	-758	-1,744	1,230	555	1,015	17	-570	-25
Free cash flow	1,914	1,895	3,758	1,847	2,090	2,310	2,832	2,686	2,055	2,423
Interest paid	348	245	177	242	336	356	323	261	243	306
Income taxes paid	67	356	188	368	148	353	558	919	867	581

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 29, 2026; growth uses fiscal years. Valuation uses the share price of $238.08 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	55.0%	Gross profit / revenue.
Operating margin	30.4%	Operating income / revenue.
EBITDA margin	36.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	27.3%	Pre-tax income / revenue.
Net margin	21.0%	Net income / revenue.
FCF margin	21.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	24.2%	Cash from operations / revenue.
Effective tax rate	19.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	24.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	9.8%	Net income / average total assets.
Return on invested capital (ROIC)	16.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	19.0%	Research and development expense / revenue.
SG&A / revenue	9.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	3.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.7%	Capital expenditures / revenue.
D&A / revenue	6.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-2.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-5.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-3.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	9.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-10.8%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-7.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	48.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-10.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-8.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	10.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-19.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-10.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	107.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-18.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-9.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	113.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	1.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-10.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	2.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	17.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-5.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	3.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	6.3%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	22.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	9.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	10.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	2.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	8.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.24x	Current assets / current liabilities.
Quick ratio	1.35x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.02x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.07x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	43.2%	Total debt / total assets.
Liabilities / assets	58.4%	Total liabilities / total assets.
Net debt	$8.02B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.73x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	8.08x	Operating income / interest expense.
Working capital	$4.51B	Current assets - current liabilities.
Goodwill and intangibles / assets	43.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$858.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.47x	Revenue / average total assets.
Fixed asset turnover	4.35x	Revenue / average property, plant and equipment.
Inventory turnover	2.25x	Cost of revenue / average inventory.
Days inventory	162 days	365 x average inventory / cost of revenue.
Receivables turnover	10.6x	Revenue / average receivables.
Days sales outstanding	34 days	365 x average receivables / revenue.
Days payables	58 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	139 days	Days inventory + days sales outstanding - days payables.
FCF conversion	102.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	11.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$10.46	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$49.76	Revenue / diluted weighted shares.
FCF per share	$10.69	Free cash flow / diluted weighted shares.
Operating cash flow per share	$12.02	Cash from operations / diluted weighted shares.
Book value per share	$43.10	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$3.38	Tangible book value / shares outstanding.
Cash per share	$14.63	(Cash + short-term investments) / shares outstanding.
Payout ratio	38.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	37.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	25.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$60.04B	Share price x shares outstanding.
Enterprise value	$68.05B	Market cap + total debt - cash - short-term investments.
P/E	22.6x	Market cap / net income. Only when net income is positive.
P/S	4.76x	Market cap / revenue.
P/B	5.49x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	22.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	19.7x	Market cap / cash from operations, when positive.
EV/Sales	5.39x	Enterprise value / revenue.
EV/EBIT	17.8x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.7x	Enterprise value / EBITDA, when both are positive.
EV/FCF	25.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.5%	Free cash flow / market cap.
Earnings yield	4.4%	Net income / market cap (the inverse of P/E).
Dividend yield	1.7%	Dividends paid over the period / market cap.
Shareholder yield	2.9%	(Dividends paid + share buybacks) / market cap.

What was NXP Semiconductors N.V.'s revenue in fiscal 2025?

NXP Semiconductors N.V. reported revenue of $12.27B for fiscal 2025, 2.7% lower than the year before.

Was NXP Semiconductors N.V. profitable in fiscal 2025?

Yes. Net income was $2.02B, a net margin of 16.5%.

How much free cash flow did NXP Semiconductors N.V. generate in fiscal 2025?

Cash from operations of $2.82B minus capital expenditures of $397.0M left free cash flow of $2.42B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NXP Semiconductors N.V.